3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
5
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neuroblastoma
3
Lymphoma
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Sertoli-Leydig Cell Tumor
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian gynandroblastoma
1
Ovarian Neoplasms
1
Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Granulosa cell tumor of the ovary
1
Glioma
1
Fallopian Tube Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Carcinoma, Ovarian Epithelial
1
Interventions
Cyclophosphamide
17
Rituximab
14
Cytarabine
9
Peripheral Blood Stem Cell Transplantation
7
Melphalan
7
Etoposide
7
Filgrastim
6
Dexamethasone
6
fludarabine phosphate
5
fludarabine
5
Radiotherapy
5
Cyclosporine
5
Carmustine
5
ibrutinib
4
Vincristine
4
Prednisone
4
Lenalidomide
4
Doxorubicin
4
Bortezomib
4
Sensitivity and Specificity
3
R-CHOP protocol
3
Mycophenolic Acid
3
Interferon-alpha
3
Indium
3
Cisplatin
3
Busulfan
3
Bendamustine Hydrochloride
3
Antilymphocyte Serum
3
Antigens, CD19
3
sargramostim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Mantle-Cell
×
etoposide phosphate
×
Clear all
NCT00946374
2009-07-27
HD-MCL2003
Heidelberg University
Phase 2
Unknown
20 enrolled